However, USP22 inhibition could not further enhance the inhibitory effect on melanoma invasion in the presence of PI3K inhibitor (GDC‐0941), Akt inhibitor (MK‐2206), or mTOR inhibitor (CCI‐779) (Figure 4F,G). The gene discussed is AKT1; the disease is melanoma.